Trial Profile
Double-blind randomized placebo-controlled multinational, multicentre-trial on prolonged macrolide treatment in patients with moderate/severe chronic rhinosinusitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Jul 2015
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary)
- Indications Rhinosinusitis
- Focus Therapeutic Use
- 15 Jul 2015 New trial record